SCHEMBL7144495

SCHEMBL7144495

Cc1[nH]c2ccc(NC(=O)c3ccc(Cl)o3)cc2c1CCN(C)C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 2/20 0.64
HTR6 P50406 4/20 0.54
HTR7 P34969 3/20 0.54
HTR2B P41595 2/20 0.54
ADRA2A P08913 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA2C P18825 1/20 0.54
HTR1A P08908 2/20 0.47
HTR1D P28221 2/20 0.47
SLC6A2 P23975 1/20 0.47
HTR1E P28566 1/20 0.47
HTR5A P47898 1/20 0.47
ALDH1A1 P00352 5/20 0.43
HPGD P15428 2/20 0.43
TERT O14746 1/20 0.43
KDM4E B2RXH2 3/20 0.42
ALOX15 P16050 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPT P10636 5/20 0.41
PRNP P04156 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7145049 0.90 HTR1F (0.67) HTR1FHTR6HTR7HTR2BADRA2A
SCHEMBL7143949 0.83 HTR1F (0.66) HTR1FHTR6HTR7HTR2BADRA2A
SCHEMBL7146412 0.82 HTR1F (0.81) HTR1FHTR6HTR7HTR2BADRA2A
SCHEMBL7145555 0.82 HTR1F (0.74) HTR1FHTR6HTR7HTR2BADRA2A
SCHEMBL7142319 0.82 HTR1F (0.67) HTR1FHTR6HTR7HTR2BADRA2A
SCHEMBL7142304 0.82 HTR1F (0.67) HTR1FHTR6HTR7HTR2BADRA2A
SCHEMBL7147525 0.82 HTR1F (0.67) HTR1FHTR6HTR7HTR2BADRA2A
SCHEMBL7136418 0.81 HTR1F (0.74) HTR1FHTR6HTR7HTR2BADRA2A
SCHEMBL7138123 0.81 HTR1F (0.71) HTR1FHTR6HTR7HTR2BADRA2A
SCHEMBL7138192 0.80 HTR1F (0.80) HTR1FHTR6HTR7HTR2BADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768301-B1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists LILLY CO ELI (US) 2003-04-02 EP disclosed
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
US-6126932-A INSOLUBLE POLYMER BEARING PENDANT SIDE CHAINS, SAID SIDE CHAINS EACH TERMINATING WITH THE 1-(3-(1-PYRROLIDINYL)-PROPYL)-3-ETHYLCARBODIIMIDE MOIETY. ELI LILLY AND COMPANY (US) 2000-10-03 US disclosed
EP-0994109-A2 1-(3-(1-Pyrrolidinyl)propyl)-3-ethylcarbodiimide and a solid phase coupling agent ELI LILLY AND COMPANY (US) 2000-04-19 EP disclosed
US-5998630-A A 1-(3-(1-PYRROLIDINYL)PROPY)-3-ETHYLCARBODIIMIDE ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
EP-0768301-A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists ELI LILLY AND COMPANY (US) 1997-04-16 EP disclosed